June 2015 FDA Recall Rifampin by Fresenius Kabi Usa, Llc
D-1234-2015 - Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradation

This Class II drug recall was voluntarily initiated by Fresenius Kabi Usa, Llc on June 4, 2015 for the product Rifampin. The FDA reported the reason for recall as failed impurities/degradation specifications; out-of-specification for color, impurity, and degradation. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1234-2015

Reason for Recall
Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradation
Initiated
06-04-2015
Reported
07-22-2015
Quantity
7,593 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Fresenius Kabi USA, LLC
Nationwide,Hawaii, and Puerto Rico
Rifampin for Injection, USP 600mg/vial in a 20mL vial, Rx only, Manufactured for Fresenius Kabi LLC 3 Corporate Drive, Lake Zurich, IL, 60047, by Fresenius Kabi LLC, 2020 N Ruby Street, Melrose Park, IL 60160. NDC 63323-351-20

Batch or Lot Expiration Information

Lot# : 6109469, 6109470, Exp 10/2016

Affected Packages Involved in this Recall